Life sciences · Journal article
Nutrients · September 20, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Background/Objectives: The fish head contains a large number of bioactive lipids for preparing functional foods. In this study, we analyzed the fatty acid components and molecular species of tilapia head phospholipids (TH-PL), and investigated the preventive effect of them on metabolic syndrome (MS). Methods: Twenty-three fatty acids were identified in TH-PL, and the percentage of n-3 PUFA and n-6 PUFA was high, occupying 48.21% of total fatty acids. And sixty-two phospholipids (PL) molecular species belonging to seven types of PL were identified using UPLC-Q-TOF-MS. The contents of the various types of TH-PL were generally in the order PC > PE > SM > PS > LPC > PI > LPE. Among them, PC (16:0/18:1), PE (P-16:0/22:4), PS (18:0/22:5), LPC (16:0), PI (16:0/20:4), LPE (18:0), and SM (d16:0/18:1) were the major molecular species of TH-PL. Moreover, animal experiments were conducted to evaluate the preventive effect of TH-PL on high-fat diet (HFD)-induced MS mice. Results: Animal experiments revealed that TH-PL could significantly inhibit obesity, improve insulin resistance and dyslipidemia in high-fat diet (HFD)-induced MS mice. Intake of TH-PL could also block lipid synthesis in the liver by modulating the expression of lipogenesis-related genes and proteins, such as up-regulation of AMPK and down-regulation of PPARγ, SREBP-1c, and FAS. In addition, TH-PL could relieve MS directly and indirectly by counteracting gut microbiota disturbance caused by HFD. Conclusions: These data suggested that it may be a good choice to develop new functional foods containing TH-PL for dietary intervention in MS.